[1] |
王莉,梁嵘,刘志辉,等.晚期肺腺鳞癌不同化疗方案疗效分析[J].西部医学,2016,28(6):840-844.
|
[2] |
王寒黎,陆志伟.多西他赛联合铂类化疗方案治疗晚期肺鳞癌与腺癌疗效分析[J].皖南医学院学报,2016,35(6):565-567.
|
[3] |
黄芳,姜达,李颖,等.晚期肺腺癌化疗方案的优化[J].肿瘤防治研究,2015,42(7):687-692.
|
[4] |
曾洁.联用AP化疗方案与补肾散结方对晚期肺腺癌患者进行治疗的效果探析[J].当代医药论丛,2016,14(23):108-109.
|
[5] |
慕竹青,韩丽娟,鲁一,等.CIK细胞联合化疗治疗中晚期肺腺癌的临床观察[J].世界临床医学,2016,10(16):78-79.
|
[6] |
李亭山,曹翠娟,周秋梅.晚期肺腺癌治疗方案分析与疗效研究[J].中国医药导刊,2016,18(9):896-897.
|
[7] |
陈荧.培美曲塞联合顺铂治疗老年肺腺癌的疗效分析[J].首都食品与医药,2016,23(20):52-54.
|
[8] |
周澄亚,王艇,韩德前,等.肺腺鳞癌预后影响因素分析及治疗方式探讨[J].现代肿瘤医学,2016,24(21):3404-3408.
|
[9] |
Mordant P,Grand B,Cazes A,et al.Adenosquamous carcinoma of the lung:surgical management,pathologic characteristics,and prognostic implications[J].Ann Thorac Surg,2013,95(4):1189-1195.
|
[10] |
吴熙,李峻岭,陈舒兰,等.72例肺腺鳞癌临床病理特点和预后因素分析[J].中国肺癌杂志,2016,19(10):653-658.
|
[11] |
Sun JM,Ahn JS,Jung SH,et al.Pemetrexed plus cisplatinversus gemcitabine plus cisplatin according to thymidylatesynthase expression in nonsquamous non-small-cell lungcancer:a biomarker-stratified randomized phase Ⅱtrial[J].J Clin Oncol,2015,33(22):2450-2456.
|
[12] |
Wang R,Pan Y,Li C,et al.Analysis of major known driver mutationsand prognosis in resected adenosquamous lung carcinomas[J].JThorac Oncol,2014,9(6):760-768.
|
[13] |
马克威,贾琳,郭晔,等.59例肺腺鳞癌患者的病理特征对其外科手术后生存的影响[J].中华胸心血管外科杂志,2014,30(11):641-644.
|
[14] |
Travis WD,Brambilla E,Burke AP,et al.Introduction to The 2015 WordHealth Organization Chassicotion of Tumors of the Lung,Pleura,Thymas,and Heart[J].J Thorat Onclo,2015,10(9):1240-1242.
|
[15] |
Lee Y,Chung JH,Kim SE,et al.Adenosquamous carcinoma of the lung:CT,FDG PET,and clinicopathologic findings[J].Clin Nucl Med,2014,39(2):107-112.
|
[16] |
Zhou C,Wu YL,Chen G,et al.Final overall survival results fromarandomised,phaseⅢstudyoferlotinibversuschemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lungcancer(Optimal,ctong-0802)[J].Ann Oncol,2015,26(9):1877-1883.
|
[17] |
李晶晶,张倩倩,朱文科,等.不同病理类型肺癌HRCT征象与三种血清肿瘤标志物的相关性[J].放射学实践,2016,31(7):630-633.
|
[18] |
杨海堂,姚烽,孙益峰,等.肺腺鳞癌外科疗效分析[J].中华胸部外科电子杂志,2015,2(3):161-167.
|
[19] |
Vignaud JM.Squamous cell carcinoma,basaloid squamouscell carcinoma and adenosquamous carcinoma in the lung[J].Ann Pathol,2016,36(1):15-23.
|